Vol. 8 Issue 6 - June 2021 |
|
The full scientific program of ISDE 2021 is almost ready to launch on the Congress website, but to whet your appetite, here are a couple of highlights:
- Assoc. Prof. Daniel Catenacci from the University of Chicago talking about Personalized Treatment Strategies for Gastro-Esophageal Adenocarcinoma - Results from the PANGEA trial.
- Prof. Rebecca Fitzgerald from Hutchison-MRC Research Centre delivering a lecture on Screening for Barrett's Esophagus - Who Deserves It and Who Doesn't?
- Session dedicated to the impact of COVID-19 on the field of esophageal diseases (Considerations for Esophageal Surgery in the COVID-Positive Patient; Pre-operative/Pre-procedural COVID Testing; Use of Personal Protective Equipment in Resource-Constrained Environments).
…and that is just the start!
Not registered yet? What are you waiting for?! Join us on September 27-30, 2021.
|
|
Live on August 11, 2021, 15:00-16:00 GMT
Join us for a live virtual presentation covering such topics as opioid induced esophageal dysfunction, non-achalasia spastic disorders (jackhammer, distal esophageal spasm), and hypomotility disorders.
If you are working in gastroenterology, surgery, nursing, research, or have an interest in diseases of the esophagus then this is the presentation for you. Register for free.
|
|
Call for Committee Members
We're looking for members who are keen to step into a more active role as a member of an ISDE Standing Committee, for the term 2021-2023. There's various committees actively recruiting including the Education Committee and Scientific Program. Fill in this form by August 5. For more details, click here.
|
|
ISDE leaders and members are celebrating 40 years of contributing to the development and dissemination of information about the esophagus. Join us in commemorating the success and impact of past ISDE World Congresses in the the following World Congress Spotlight Series.
|
|
The 13th ISDE World Congress was held in Venice, Italy, in October 2012. It was presided over by Professors Ermanno Ancona, Giovanni Zaninotto, and Francesco Di Mario. The ISDE President was Professor Jan Tack. The venue, on Venice Lido, a barrier island, was very relaxed and historic. The 14th ISDE World Congress took place in Vancouver, Canada, in September 2014 (see photo)). This was the first ISDE Congress that was organized by the new ISDE management firm, International Conference Services (ICS), rather than being planned and hosted by a local ISDE leader. Read the full thirteenth and fourteenth congress spotlight. |
|
Dote Impact Factor Increased
The Journal Citation Reports™ have been released and we're thrilled to announce that #DOTEsophagus has increased its influence in the field with an Impact Factor of 3.429. It represents an excellent achievement for the journal, which now ranks 59 on 92 gastroenterological journals. Congratulations to the DOTE Journal team and we appreciate your work and enthusiasm! Read more.
|
|
Welcoming our New Associate Editor for Social Media, Dr. Jessie Elliot
Introducing you to our new Associate Editor for Social Media, Dr. Jessie Elliott! Jessie is a young, brilliant researcher at Trinity College and the Trinity St. James’s Cancer Institute in Dublin, Ireland, and she chairs the Young Investigator Group of the European Society of Esophageal Diseases. She will be responsible for expanding our journal's visibility among virtual communities and social media platforms. We are thrilled to welcome Jessie as a member of the Diseases of the Esophagus editorial board.
|
|
Check out the latest DOTE issue for articles on Benign Esophageal and Malignant Esophageal Diseases; See the full table of contents.
|
|
|
DOTE Volume 34, Issue 7 | Editor's Choice
Free Article
Paraesophageal hernias (PEHs) present with a variety of symptoms and can have significant impact on patients’ quality of life (QOL) as a result of herniation of the abdominal viscera, most frequently the stomach, into the posterior mediastinum. In many cases, PEHs are incidental findings on imaging studies and are asymptomatic, but for a proportion of patients with larger hernias, the symptoms can have a substantial impact upon their QOL and functional status. Read the full article.
DOTE Volume 34, Issue 7 | Editor's Choice (Quick Shot Review)
Free Article
No approved medications exists for the treatment of eosinophilic esophagitis (EoE) in the United States. In the study of 27 patients, compounded fluticasone suspension (mixture of powdered fluticasone with a Methocel gel) was used for treatment and assessed for outcomes after a mean treatment length of 5.4+4.4 months.
- In patients who had primary nonresponse or secondary loss of response to elimination diet or topical steroids, compounded fluticasone showed improvement in symptoms (dysphagia, rates of food impaction, chest pain) and endoscopic findings (white plaques).
- Overall, 35% of patients achieved histologic remission (<15 eos/hpf) with compounded fluticasone and median eosinophils decreased from 52 to 37 eos/hpf (p=0.1).
|
|
DOTE Volume 34, Issue 7 | Quick Shot Article Review
Members Only Access
The optimal perioperative fluid management during esophagectomy is unclear. This study sought to evaluate if fluid administration or vasopressor use intraoperatively and during postoperative period correlated with postoperative respiratory outcomes.
- Patients were divided into three groups:
- GRP0 (no fluid overload/no vasopressors) (=reference group)
- GRP1 (no fluid overload/need for vasopressors)
- GRP2 (fluid overload + vasopressors).
- The GRP2 group (patients who had fluid overload) had a 9.22 higher risk of developing postoperative respiratory complications.
- The GRP1 group (patients who received vasopressin) had a 3.12 higher risk of developing postoperative respiratory complications.
-
There is a higher incidence of postoperative respiratory complications when patients received higher amounts of fluid or when vasopressors during or after esophagectomy.
|
|
Follow us on Social Media! |
|
|
|
|
|
|
